JANSSEN BIOTECH INC

Janssen Biotech Inc. specializes in the manufacturing of specialized pharmaceutical preparations, with a focused expertise in oncology and hematology therapeutics, including targeted small-molecule drugs and bulk active pharmaceutical ingredients. The company delivers precision-manufactured drug products such as BALVERSA (erdafitinib) in multiple dosages and formulations, demonstrating advanced capabilities in GMP-compliant production, drug substance handling, and finished dosage form supply chain management. Their technical proficiency includes aseptic processing, batch consistency validation, and regulatory-grade documentation for complex oncology agents, supporting mission-critical patient access for chronic and rare disease indications. The Department of Veterans Affairs is the primary federal partner, consistently procuring pharmaceuticals for veteran healthcare systems, particularly hematologic malignancies and targeted cancer therapies. Janssen Biotech’s sustained engagement with VA reflects a trusted, repeat supplier relationship built on reliable delivery of high-complexity oncology drugs under the Federal Supply Schedule and blanket purchase agreements, ensuring uninterrupted access to life-saving medications within the VA’s national pharmacy network. The contractor’s core operations are centered on NAICS 325412—Pharmaceutical Preparation Manufacturing—where they function as a niche producer of branded, FDA-approved oncology therapeutics, positioning themselves within the specialty pharmaceutical market for government healthcare systems. Their work supports the delivery of precision medicine through tightly controlled manufacturing processes and stringent quality assurance protocols aligned with current Good Manufacturing Practices. Janssen Biotech Inc. operates as a corporate entity headquartered in Horsham, Pennsylvania, with no public certifications on record. The company maintains a focused geographic footprint aligned with federal pharmaceutical supply chains, serving as a critical node in the government’s secure and compliant drug procurement infrastructure for veteran and public health programs.